- 9 days & nights inpatient stay
- 3 quick follow-up appointments
Participants will be reimbursed $2,760 for participating in this study and this clinical trial has been approved by an independent ethics committee.
About the study
We require healthy participants who do not have any medical conditions for the initial stage of this medical research.
This study is looking at a new treatment for vision loss due to a condition known as Stargardt’s disease. Stargardt’s disease is a genetic condition which leads to vision loss due to damage to several parts of the eye. The medication is administered via oral capsules which you will swallow with a glass of water.
How do I find out more?
If you have already registered with us but would like more information about this study, please call 1800 243 733 or schedule a call back. You can also email us at email@example.com quoting “Star Study”.
If you are interested in participating and have not previously registered as a participant with us, fill in your details in the form below and we’ll be in touch soon!